Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
After-Hours: 20:00
Collegium Pharmaceutical Profit Margin (Quarterly): 5.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.86% |
| June 30, 2024 | 13.50% |
| March 31, 2024 | 19.12% |
| December 31, 2023 | 21.33% |
| September 30, 2023 | 15.09% |
| June 30, 2023 | 9.60% |
| March 31, 2023 | -12.04% |
| December 31, 2022 | -5.55% |
| September 30, 2022 | 0.36% |
| June 30, 2022 | -4.20% |
| March 31, 2022 | -15.60% |
| December 31, 2021 | -91.49% |
| September 30, 2021 | 10.21% |
| June 30, 2021 | 87.82% |
| March 31, 2021 | 17.85% |
| December 31, 2020 | 9.12% |
| September 30, 2020 | 14.25% |
| Date | Value |
|---|---|
| June 30, 2020 | 10.32% |
| March 31, 2020 | 0.59% |
| December 31, 2019 | -2.97% |
| September 30, 2019 | -8.38% |
| June 30, 2019 | -6.28% |
| March 31, 2019 | -13.02% |
| December 31, 2018 | 12.37% |
| September 30, 2018 | -23.52% |
| June 30, 2018 | -17.88% |
| March 31, 2018 | -29.26% |
| December 31, 2017 | -161.2% |
| September 30, 2017 | -111.0% |
| June 30, 2017 | -593.3% |
| March 31, 2017 | -1.06K% |
| December 31, 2016 | -2.12K% |
| September 30, 2016 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-91.49%
Minimum
Dec 2021
87.82%
Maximum
Jun 2021
5.16%
Average
9.36%
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -4.75% |
| Insmed Inc | -236.0% |
| Pulmonx Corp | -69.38% |
| RxSight Inc | -17.95% |
| Context Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 42.30% |
| Return on Assets | 7.23% |
| Return on Invested Capital | 9.91% |
| Gross Profit Margin (Quarterly) | 60.76% |
| Operating Margin (Quarterly) | 21.87% |
| Return on Net Operating Assets | 9.79% |